OCT 09, 2020 5:07 PM PDT

Using CRISPR to Destroy Cancer Cells

WRITTEN BY: Carmen Leitch

A few days ago, researchers and Professors Jennifer Doudna and Emmanuelle Charpentier won the Nobel prize in Chemistry for their work developing the gene editor CRISPR/Cas9. Since it was created, the gene editor has been used in many ways in research labs and has even moved to human trials in the clinic.

Some diseases can be traced back to genetic errors, and in some cases, those errors have the potential to be repaired by the CRISPR/Cas9 system. In new research, scientists have now applied it to tumor cells in an effort to eliminate something called fusion genes; fusion oncogenes are only found in cancer cells. The work has been reported in Nature Communications.

Fusion genes come from the aberrant joining of fragments of DNA that arise from two different genes, an error that can occur during cell division. Cells that carry deleterious fusion genes will often simply die, but in some cases, the cell is unharmed by the fusion gene; the cell carrying the fusion gene may have a reproductive advantage that causes it to start multiplying and leads to the formation of a tumor in the case of fusion oncogenes.

"Many chromosomal rearrangements and the fusion genes they produce are at the origin of childhood sarcomas and leukemias," noted the lead co-author of the study, Sandra Rodríguez-Perales.

An untreated tumour on the left and on the right, a CRISPR-treated tumor. Cells are stained with a cell proliferation marker (Ki67); brown shows cells in the untreated tumour proliferating, but not in the CRISPR-treated tumour / Credit: CNIO

Fusion genes have been found in many tumor cells; they may be present in up to twenty percent of cancers including breast, brain, and lung tumors. Fusion oncogenes are an attractive therapeutic target because they’re not found in healthy cells.

CRISPR/Cas9 can target very specific places in the genome for edits. In this work, the researchers used it to remove fusion genes from cells and mouse models of both Ewing's sarcoma and chronic myeloid leukemia. The researchers tried to make the tumors destroy themselves.

 "Our strategy was to make two cuts in introns, non-coding regions of a gene, located at both ends of the fusion gene," explained study co-author Raúl Torres-Ruiz. "In that way, in trying to repair those breaks on its own, the cell will join the cut ends which will result in the complete elimination of the fusion gene located in the middle.” This particular gene is required for the cell to survive, so once the repair was made, the tumor cell died.

"Our next steps will be to carry out more studies to analyze the safety and efficiency of our approach," added Rodríguez-Perales. "These steps are essential to know if our approach can be translated in the future into a potential clinical treatment. Furthermore, we will study whether our strategy, which we have already seen works in Ewing's sarcoma and chronic myeloid leukemia, is also effective in other types of cancer caused by fusion genes and for which there are currently no effective therapies."

Sources: AAAS/Eurekalert! via Centro Nacional de Investigaciones Oncológicas (CNIO), Nature Communications

 

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 26, 2021
Genetics & Genomics
Why Only Some People With a Rare Mutation Get a Heart Condition
JAN 26, 2021
Why Only Some People With a Rare Mutation Get a Heart Condition
Scientists have found a way to explain why a heart condition called hypertrophic cardiomyopathy (HCM) can be so differen ...
FEB 16, 2021
Cell & Molecular Biology
A Change in One Gene Might've Made Our Brains Uniquely Human
FEB 16, 2021
A Change in One Gene Might've Made Our Brains Uniquely Human
Stem cells can be used to create simplified versions of human organs called organoids, enabling researchers to study how ...
MAR 08, 2021
Microbiology
Researchers Discover a New Symbiosis
MAR 08, 2021
Researchers Discover a New Symbiosis
A new type of endosymbiosis has been discovered; the organisms are shown in this image by S. Ahmerkamp, Max Planck Insti ...
MAR 14, 2021
Genetics & Genomics
How Stress Increases the Risk of Preterm Birth
MAR 14, 2021
How Stress Increases the Risk of Preterm Birth
Preterm birth is when a baby is born before the 37th week of pregnancy. The liver, lungs & brain undergo a crucial devel ...
MAR 18, 2021
Drug Discovery & Development
New Cancer Immunotherapy Targets Genetic Alteration in All Cancers
MAR 18, 2021
New Cancer Immunotherapy Targets Genetic Alteration in All Cancers
Researchers have developed a prototype for a new kind of cancer immunotherapy. The therapy uses engineered T-cells to ta ...
APR 05, 2021
Genetics & Genomics
Understanding Why Redheads Perceive Pain Differently
APR 05, 2021
Understanding Why Redheads Perceive Pain Differently
People with red hair, as well as some animals that have red fur, carry one variation of a gene called melanocortin 1 rec ...
Loading Comments...